<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27737406</article-id><article-id pub-id-type="pmc">5062709</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160047</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Endovascular Abdominal Aneurysm Repair in Women: What are the
Differences Between the Genders?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Machado</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Gabriela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Pedro</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>PhD</role></contrib><contrib contrib-type="author"><name><surname>Loureiro</surname><given-names>Lu&#x000ed;s</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib></contrib-group><aff id="aff1"><label>1</label>Hospital de Santo Ant&#x000f3;nio - Centro Hospitalar do
Porto, Porto, Portugal</aff><aff id="aff2"><label>2</label>Instituto de Ci&#x000ea;ncias Biom&#x000e9;dicas Abel
Salazar (ICBAS), Porto, Portugal</aff><author-notes><corresp id="c1"><bold>Correspondence Address:</bold> Gabriela Teixeira Hospital de
Santo Ant&#x000f3;nio, Centro Hospitalar do Porto, Largo Professor Abel Salazar -
Porto, Portugal - 4099-001. E-mail: <email>tgabrielateixeira@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2016</year></pub-date><volume>31</volume><issue>3</issue><fpage>232</fpage><lpage>238</lpage><history><date date-type="received"><day>09</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>04</day><month>7</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>INTRODUCTION:</title><p>Abdominal aortic aneurysm has a lower incidence in the female population, but
a higher complication rate. It was been hypothesized that some anatomical
differences of abdominal aortic aneurysm in women could be responsible for
that. We proposed to analyze our data to understand the differences in the
clinical and anatomical characteristics and the outcomes of patients
undergoing endovascular aneurysm repair, according to gender.</p></sec><sec><title>METHODS:</title><p>A retrospective analysis of patients undergoing endovascular aneurysm repair
between 2001-2013 was performed. Patients were divided according gender and
evaluated regarding age, atherosclerotic risk factors, aneurysm anatomic
features, endograft type, anesthesic risk classification, length of stay,
reinterventions and mortality. Two statistical studies were performed, first
comparing women and men (Group A) and a second one comparing women and men,
adjusted by age (Group B).</p></sec><sec><title>RESULTS:</title><p>Of the 171 patients, only 5.8% (n=10) were females. Women were older
(<italic>P</italic>&#x0003c;0.05) and the number of women with no
atherosclerotic risk factor was significantly higher. The comparison
adjusted by age revealed women with statistically less smoking history, less
cerebrovascular disease and ischemic heart disease. Women had a trend to
more complex anatomy, with more iliac intern artery aneurysms, larger
aneurysm diameter and neck angulations statistically more elevated. No other
variables were statistically different between age groups, neither
reintervention nor mortality rates.</p></sec><sec><title>CONCLUSION:</title><p>Our study showed a clear difference in the clinical characteristics of women.
The female population was statistically older, and when compared with men
adjusted by age, had less atherosclerotic risk factors and less target organ
disease. Women showed a more complex anatomy but with the same outcomes.</p></sec></abstract><kwd-group><kwd>Aortic Aneurysm</kwd><kwd>Abdominal</kwd><kwd>Endovascular Procedures</kwd><kwd>Women</kwd></kwd-group></article-meta></front><body><p><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Abbreviations, acronyms &#x00026;
symbols</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">AAA</td><td rowspan="1" colspan="1">= Abdominal aortic aneurysm</td></tr><tr><td rowspan="1" colspan="1">ASA</td><td rowspan="1" colspan="1">= American Society of Anesthesiologists</td></tr><tr><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">= Body mass index</td></tr><tr><td rowspan="1" colspan="1">EVAR</td><td rowspan="1" colspan="1">= Endovascular aneurysm repair</td></tr></tbody></table></table-wrap>
</p><sec sec-type="intro"><title>INTRODUCTION</title><p>Abdominal aortic aneurysm (AAA) has a lower incidence in the female
population<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>, but a higher
complication rate<sup>[<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r5" ref-type="bibr">5</xref>]</sup>, especially a higher risk of rupture<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. It was been hypothesized that some
different clinical and anatomical characteristics of AAAs in women could be
responsible for this higher rate of complications and worse results after
treatment.</p><p>As the incidence of AAAs is higher in men, the therapeutic indications for AAAs in
women are generally extrapolated from studies that have a small number of women, and
so they are based mostly on results obtained from men.</p><p>We decided to evaluate in our center if gender had influence on the clinical,
anatomical characteristics and outcomes after endovascular aneurysm repair
(EVAR).</p></sec><sec sec-type="methods"><title>METHODS</title><p>A retrospective analysis of our database of patients undergoing EVAR was performed. A
total of 171 patients treated between October 2001 and December 2013 and with a
diagnosis of infrarenal aortic or aortoiliac aneurysms were included. The adopted
surgical criteria were degenerative fusiform aneurysm diameter &#x0003e;5 cm, aortic
aneurysm &#x0003c;5 cm associated with common iliac artery aneurysm &#x0003e;3 cm, saccular
aneurysms, dissecting aneurysms and pseudoaneurysms. Patients with a diagnosis of
ruptured abdominal aneurysm were excluded.</p><p>Patients were divided according gender and evaluated regarding age, atherosclerotic
risk factors (hypertension, diabetes, smoke history, dyslipidemia), body mass index
(BMI), comorbidities (ischemic heart disease, valvular heart disease, heart failure,
cardiac arrhythmia, vascular neurological disease, chronic obstructive pulmonary
disease, respiratory failure, chronic kidney disease), aneurysm morphology (aortic,
right aortoiliac, left aortoiliac, bilateral aortoiliac), aneurysm diameter, neck
form (conical, reverse conical, cylindrical, other), neck characteristics (diameter,
calcification, thrombus, angulation), iliac morphology (tortuosity and diameter),
anatomical risks, internal iliac artery aneurysms, endograft type, American Society
of Anesthesiologists (ASA) classification, anesthetic technique, length of stay,
reinterventions, and mortality.</p><p>Two statistical analysis were performed, the first comparing women (n=10) and men
(n=161) (Group A), and the second comparing women (n=10) and an age-adjusted
subgroup of men (n=47) (Group B). The statistical analysis included t-tests for two
independent samples, analyses of variance in the case of several groups, and
chi-square tests for the comparison of proportions concerning categorical variables.
Nonparametric tests were used when the normality or homogeneity of variances was not
observed. All the analyses were performed with IBM SPSS Statistics, version 22; the
statistical significance for twosided tests was assumed to be
<italic>P</italic>&#x0003c;0.05.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Of the 171 patients, 94.2% (n=161) were males and 5.8% (n=10) were females. We
analyzed patients undergoing open surgery during the same period and found that 5%
were women, with no statistical difference between the proportions
(<italic>P</italic>=0.478). The mean age of patients undergoing EVAR was 74.1
years, with the median of 75 years and a standard deviation of 8.9 (min.: 38, max.:
93). In the male population, the mean age was 73.8&#x000b1;8.9 years, while women's
was 79.8&#x000b1;6.9 years. The female population was statistically older
(<italic>P</italic>=0.037).</p><p>Clinical characteristics comparison between gender is shown in <xref ref-type="table" rid="t1">Table 1</xref>. In group A, women had statistically fewer association
with smoking history, association of atherosclerotic risk factors, and fewer
vascular neurological disease, and a trend to a fewer arterial hypertension. In
Group B, women had statistically fewer association with smoking history, ischemic
heart disease, vascular neurological disease, and a trend to fewer arterial
hypertension and atherosclerotic risk factors association.</p><p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Comparison of clinical characteristics between women and men (Groups A
and B).</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><colgroup span="1"><col width="15%" span="1"/><col width="10%" span="1"/><col width="15%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th colspan="3" rowspan="2" align="left">&#x000a0;</th><th colspan="2" align="center" rowspan="1"><bold>Group A (general)</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th><th colspan="2" align="center" rowspan="1"><bold>Group B (adjusted by
age)</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Men (n=161)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women (n=10)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Men (n=47)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women (n=10)</bold></th></tr></thead><tbody><tr><td colspan="2" rowspan="3">Body Mass Index</td><td rowspan="1" colspan="1">BMI &#x0003c; 25</td><td align="center" rowspan="1" colspan="1">41.8%</td><td align="center" rowspan="1" colspan="1">33.3%</td><td rowspan="3" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">52.3%</td><td align="center" rowspan="1" colspan="1">33.3%</td><td rowspan="3" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">BMI 25-30</td><td align="center" rowspan="1" colspan="1">36.2%</td><td align="center" rowspan="1" colspan="1">66.7%</td><td align="center" rowspan="1" colspan="1">34.1%</td><td align="center" rowspan="1" colspan="1">66.7%</td></tr><tr><td rowspan="1" colspan="1">BMI&#x0003e; 30</td><td align="center" rowspan="1" colspan="1">22%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">13.6%</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td colspan="2" rowspan="1">Hypertension</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">85.7%</td><td align="center" rowspan="1" colspan="1">40%</td><td align="center" rowspan="1" colspan="1">0.053</td><td align="center" rowspan="1" colspan="1">87.2%</td><td align="center" rowspan="1" colspan="1">40%</td><td align="center" rowspan="1" colspan="1">0.062</td></tr><tr><td colspan="2" rowspan="1">Diabetes</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">18.1%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">23.9%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="2" rowspan="1">Dyslipidemia</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">68.1%</td><td align="center" rowspan="1" colspan="1">60%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">73.9%</td><td align="center" rowspan="1" colspan="1">60%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="2" rowspan="3">Smokers</td><td rowspan="1" colspan="1">Active Smokers</td><td align="center" rowspan="1" colspan="1">17.5%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">Y</td><td align="center" rowspan="1" colspan="1">13%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">Y</td></tr><tr><td rowspan="1" colspan="1">Former Smokers</td><td align="center" rowspan="1" colspan="1">61.9%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">Y</td><td align="center" rowspan="1" colspan="1">65.2%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">Y</td></tr><tr><td rowspan="1" colspan="1">No Smokers</td><td align="center" rowspan="1" colspan="1">31.4%</td><td align="center" rowspan="1" colspan="1">90%</td><td align="center" rowspan="1" colspan="1">Y</td><td align="center" rowspan="1" colspan="1">21.8%</td><td align="center" rowspan="1" colspan="1">90%</td><td align="center" rowspan="1" colspan="1">Y</td></tr><tr><td colspan="2" rowspan="1">Peripheral Arterial Disease</td><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">18.1%</td><td align="center" rowspan="1" colspan="1">81.9%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">23.9%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="2" rowspan="4">Atherosclerotic risk factors
association</td><td rowspan="1" colspan="1">No risk factor</td><td align="center" rowspan="1" colspan="1">8.1%</td><td align="center" rowspan="1" colspan="1">30%</td><td rowspan="4" align="center" colspan="1">Y</td><td align="center" rowspan="1" colspan="1">8.5%</td><td align="center" rowspan="1" colspan="1">30%</td><td rowspan="4" align="center" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">1-2 risk factors</td><td align="center" rowspan="1" colspan="1">24.2%</td><td align="center" rowspan="1" colspan="1">40%</td><td align="center" rowspan="1" colspan="1">21.3%</td><td align="center" rowspan="1" colspan="1">40%</td></tr><tr><td rowspan="1" colspan="1">3-4 risk factors</td><td align="center" rowspan="1" colspan="1">56.5%</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">63.8%</td><td align="center" rowspan="1" colspan="1">30%</td></tr><tr><td rowspan="1" colspan="1">&#x02265; 5 risk factors</td><td align="center" rowspan="1" colspan="1">11.2%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">6.4%</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td colspan="3" rowspan="1">Ischemic Heart Disease</td><td align="center" rowspan="1" colspan="1">54.50%</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">68.9%</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">Y</td></tr><tr><td colspan="3" rowspan="1">Valvular Heart Disease</td><td align="center" rowspan="1" colspan="1">26.70%</td><td align="center" rowspan="1" colspan="1">33.3%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">31.6%</td><td align="center" rowspan="1" colspan="1">33.3%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="3" rowspan="1">Heart failure</td><td align="center" rowspan="1" colspan="1">43.90%</td><td align="center" rowspan="1" colspan="1">60%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">54.5%</td><td align="center" rowspan="1" colspan="1">60%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="3" rowspan="1">Cardiac arrhythmia</td><td align="center" rowspan="1" colspan="1">36.50%</td><td align="center" rowspan="1" colspan="1">50%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">52%</td><td align="center" rowspan="1" colspan="1">50%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="3" rowspan="1">Vascular neurological disease</td><td align="center" rowspan="1" colspan="1">12.70%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">Y</td><td align="center" rowspan="1" colspan="1">14.9%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">Y</td></tr><tr><td colspan="3" rowspan="1">COPD</td><td align="center" rowspan="1" colspan="1">24.30%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">26.7%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="3" rowspan="1">Respiratory Failure</td><td align="center" rowspan="1" colspan="1">5.30%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">11.1%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td colspan="3" rowspan="1">Chronic Kidney Disease</td><td align="center" rowspan="1" colspan="1">22.10%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">17.4%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td rowspan="3" colspan="1">ASA classification</td><td colspan="2" rowspan="1">ASA II</td><td align="center" rowspan="1" colspan="1">15.8%</td><td align="center" rowspan="1" colspan="1">11.11%</td><td rowspan="3" align="center" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">9.3%</td><td align="center" rowspan="1" colspan="1">11.1%</td><td rowspan="3" align="center" colspan="1">N</td></tr><tr><td colspan="2" rowspan="1">ASA III</td><td align="center" rowspan="1" colspan="1">71.7%</td><td align="center" rowspan="1" colspan="1">55.6%</td><td align="center" rowspan="1" colspan="1">72.1%</td><td align="center" rowspan="1" colspan="1">55.6%</td></tr><tr><td colspan="2" rowspan="1">ASA IV</td><td align="center" rowspan="1" colspan="1">12.5%</td><td align="center" rowspan="1" colspan="1">33.3%</td><td align="center" rowspan="1" colspan="1">18.6%</td><td align="center" rowspan="1" colspan="1">33.3%</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>SS=statistical significance; Y=yes; N=no; ASA=American Society of
Anesthesiologists; COPD=chronic obstructive pulmonary disease</p></fn></table-wrap-foot></table-wrap>
</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Survival curves by gender.</p></caption><graphic xlink:href="rbccv-31-03-0232-g01"/></fig>
</p><p>Detailed aneurysm characteristics are shown in <xref ref-type="table" rid="t2">Table
2</xref>. There was a statistical association between neck angulation &#x0003e;70&#x000ba;
and women and a trend to statistical significance in the association of internal
iliac aneurysm and aneurysm diameter &#x0003e;60 mm, in both groups. In group A, a trend
to CIA diameter &#x0003e;20 mm in women that wasn't confirmed when adjusted by age (Group
B) was observed.</p><p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparison of aneurysm characteristics between women and men (Groups A
and B).</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><thead><tr><th colspan="2" rowspan="2" align="left">&#x000a0;</th><th colspan="2" align="center" rowspan="1"><bold>Group A (general)</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th><th colspan="2" align="center" rowspan="1"><bold>Group B (adjusted by
age)</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Men (n=161)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women (n=10)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Men (n=47)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women (n=10)</bold></th></tr></thead><tbody><tr><td rowspan="3" colspan="1">Aneurysm Morphology</td><td rowspan="1" colspan="1">Aortic</td><td align="center" rowspan="1" colspan="1">67.2%</td><td align="center" rowspan="1" colspan="1">40%</td><td rowspan="3" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">68%</td><td align="center" rowspan="1" colspan="1">40%</td><td rowspan="3" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Unilateral Aortolliac</td><td align="center" rowspan="1" colspan="1">21.8%</td><td align="center" rowspan="1" colspan="1">40%</td><td align="center" rowspan="1" colspan="1">19.1%</td><td align="center" rowspan="1" colspan="1">40%</td></tr><tr><td rowspan="1" colspan="1">Bilateral Aortolliac</td><td align="center" rowspan="1" colspan="1">11.2%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">12.8%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td rowspan="1" colspan="1">IIA Aneurysm</td><td rowspan="2" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">8.9%</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">0.07</td><td align="center" rowspan="1" colspan="1">8.5%</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">Aneurysm Diameter</td><td align="center" rowspan="1" colspan="1">62.1mm</td><td align="center" rowspan="1" colspan="1">66.7mm</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">60.2mm</td><td align="center" rowspan="1" colspan="1">66.7mm</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td rowspan="2" colspan="1">Aneurysm Diameter</td><td rowspan="1" colspan="1">&#x0003c;60 mm</td><td align="center" rowspan="1" colspan="1">48.3%</td><td align="center" rowspan="1" colspan="1">20%</td><td rowspan="2" align="center" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">48.9%</td><td align="center" rowspan="1" colspan="1">20%</td><td rowspan="2" align="center" colspan="1">0.092</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;60 mm</td><td align="center" rowspan="1" colspan="1">51.7%</td><td align="center" rowspan="1" colspan="1">80%</td><td align="center" rowspan="1" colspan="1">51.1%</td><td align="center" rowspan="1" colspan="1">80%</td></tr><tr><td rowspan="2" colspan="1">Neck length</td><td rowspan="1" colspan="1">&#x0003c;10 mm</td><td align="center" rowspan="1" colspan="1">11.2%</td><td align="center" rowspan="1" colspan="1">0</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">15%</td><td align="center" rowspan="1" colspan="1">0</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;10 mm</td><td align="center" rowspan="1" colspan="1">88.8%</td><td align="center" rowspan="1" colspan="1">100%</td><td align="center" rowspan="1" colspan="1">85%</td><td align="center" rowspan="1" colspan="1">100%</td></tr><tr><td rowspan="2" colspan="1">Neck diameter</td><td rowspan="1" colspan="1">&#x0003c;28 mm</td><td align="center" rowspan="1" colspan="1">85.7%</td><td align="center" rowspan="1" colspan="1">87.5%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">97.5%</td><td align="center" rowspan="1" colspan="1">87.5%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;28 mm</td><td align="center" rowspan="1" colspan="1">14.3%</td><td align="center" rowspan="1" colspan="1">12.5%</td><td align="center" rowspan="1" colspan="1">2.5%</td><td align="center" rowspan="1" colspan="1">12.5%</td></tr><tr><td rowspan="2" colspan="1">Neck calcification</td><td rowspan="1" colspan="1">&#x0003c;50%</td><td align="center" rowspan="1" colspan="1">95.9%</td><td align="center" rowspan="1" colspan="1">87.5%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">95.2%</td><td align="center" rowspan="1" colspan="1">87.5%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;50%</td><td align="center" rowspan="1" colspan="1">4.1%</td><td align="center" rowspan="1" colspan="1">12.5%</td><td align="center" rowspan="1" colspan="1">4.8%</td><td align="center" rowspan="1" colspan="1">12.5%</td></tr><tr><td rowspan="3" colspan="1">Neck thrombus</td><td rowspan="1" colspan="1">&#x0003c;50%</td><td align="center" rowspan="1" colspan="1">84.9%</td><td align="center" rowspan="1" colspan="1">87.5%</td><td rowspan="3" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">87.8%</td><td align="center" rowspan="1" colspan="1">87.5%</td><td rowspan="3" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;50%</td><td align="center" rowspan="1" colspan="1">15.1%</td><td align="center" rowspan="1" colspan="1">12.5%</td><td align="center" rowspan="1" colspan="1">12.2%</td><td align="center" rowspan="1" colspan="1">12.5%</td></tr><tr><td rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">18.3%</td><td align="center" rowspan="1" colspan="1">12.5%</td><td align="center" rowspan="1" colspan="1">9.5%</td><td align="center" rowspan="1" colspan="1">12.5%</td></tr><tr><td rowspan="4" colspan="1">Neck angulation</td><td rowspan="1" colspan="1">&#x0003c;50&#x000b0;</td><td align="center" rowspan="1" colspan="1">48.6%</td><td align="center" rowspan="1" colspan="1">25%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">50%</td><td align="center" rowspan="1" colspan="1">25%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;50&#x000b0;</td><td align="center" rowspan="1" colspan="1">33.1%</td><td align="center" rowspan="1" colspan="1">62.5%</td><td align="center" rowspan="1" colspan="1">40.5%</td><td align="center" rowspan="1" colspan="1">62.5%</td></tr><tr><td rowspan="1" colspan="1">&#x0003c;70&#x000b0;</td><td align="center" rowspan="1" colspan="1">92.3%</td><td align="center" rowspan="1" colspan="1">62.5%</td><td rowspan="2" align="center" colspan="1">Y</td><td align="center" rowspan="1" colspan="1">92%</td><td align="center" rowspan="1" colspan="1">62.5%</td><td rowspan="2" align="center" colspan="1">Y</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;70&#x000b0;</td><td align="center" rowspan="1" colspan="1">7.7%</td><td align="center" rowspan="1" colspan="1">37.5%</td><td align="center" rowspan="1" colspan="1">7.1%</td><td align="center" rowspan="1" colspan="1">37.5%</td></tr><tr><td rowspan="4" colspan="1">Neck shape</td><td rowspan="1" colspan="1">Conical</td><td align="center" rowspan="1" colspan="1">28.2%</td><td align="center" rowspan="1" colspan="1">25%</td><td rowspan="4" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">24.4%</td><td align="center" rowspan="1" colspan="1">25%</td><td rowspan="4" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Reversal Conical</td><td align="center" rowspan="1" colspan="1">4.9%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2.4%</td><td align="center" rowspan="1" colspan="1">0%</td></tr><tr><td rowspan="1" colspan="1">Cylindrical</td><td align="center" rowspan="1" colspan="1">63.4%</td><td align="center" rowspan="1" colspan="1">75%</td><td align="center" rowspan="1" colspan="1">73.2%</td><td align="center" rowspan="1" colspan="1">75%</td></tr><tr><td rowspan="1" colspan="1">Other</td><td align="center" rowspan="1" colspan="1">3.5%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="2" colspan="1">Iliac Tortuosity</td><td rowspan="1" colspan="1">Small/Medium</td><td align="center" rowspan="1" colspan="1">76.4%</td><td align="center" rowspan="1" colspan="1">40%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">66.7%</td><td align="center" rowspan="1" colspan="1">40%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Large</td><td align="center" rowspan="1" colspan="1">23.6%</td><td align="center" rowspan="1" colspan="1">60%</td><td align="center" rowspan="1" colspan="1">33.3%</td><td align="center" rowspan="1" colspan="1">60%</td></tr><tr><td rowspan="2" colspan="1">Right CIA Diameter</td><td rowspan="1" colspan="1">&#x0003c;20 mm</td><td align="center" rowspan="1" colspan="1">75.2%</td><td align="center" rowspan="1" colspan="1">50%</td><td rowspan="2" align="center" colspan="1">0.051</td><td align="center" rowspan="1" colspan="1">77.5%</td><td align="center" rowspan="1" colspan="1">50%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;20 mm</td><td align="center" rowspan="1" colspan="1">14.8%</td><td align="center" rowspan="1" colspan="1">50%</td><td align="center" rowspan="1" colspan="1">22.5%</td><td align="center" rowspan="1" colspan="1">50%</td></tr><tr><td rowspan="2" colspan="1">Left CIA Diameter</td><td rowspan="1" colspan="1">&#x0003c;20 mm</td><td align="center" rowspan="1" colspan="1">75.2%</td><td align="center" rowspan="1" colspan="1">55.6%</td><td rowspan="2" align="center" colspan="1">0.056</td><td align="center" rowspan="1" colspan="1">82.5%</td><td align="center" rowspan="1" colspan="1">55.6%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x0003e;20 mm</td><td align="center" rowspan="1" colspan="1">14.8%</td><td align="center" rowspan="1" colspan="1">44.4%</td><td align="center" rowspan="1" colspan="1">17.5%</td><td align="center" rowspan="1" colspan="1">44%</td></tr><tr><td rowspan="1" colspan="1">Right EIA</td><td rowspan="2" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">8.7%</td><td align="center" rowspan="1" colspan="1">9.2%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">8.8%</td><td align="center" rowspan="1" colspan="1">9.2%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Left EIA</td><td align="center" rowspan="1" colspan="1">8.5%</td><td align="center" rowspan="1" colspan="1">8.3%</td><td align="center" rowspan="1" colspan="1">N</td><td align="center" rowspan="1" colspan="1">8.5%</td><td align="center" rowspan="1" colspan="1">9.3%</td><td align="center" rowspan="1" colspan="1">N</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>IIA=internal iliac artery; CIA=common iliac artery; EIA=external
iliac artery</p></fn></table-wrap-foot></table-wrap>
</p><p>The outcomes (anesthesic time, surgical time, need of blood transfusion, lenght of
stay, type of endoleak, sac behaviour, intraoperative complications, surgical
re-intervention, thirty-day complications, and thirty-day mortality) showed no
statistical difference between gender in the two groups (<xref ref-type="table" rid="t3">Tables 3</xref> to <xref ref-type="table" rid="t6">6</xref>).</p><p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Gender and anesthesic time, surgical time, need for blood transfusion,
and length of stay (Groups A and B).</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><thead><tr><th colspan="2" rowspan="2" align="left">&#x000a0;</th><th colspan="2" align="center" rowspan="1"><bold>Anesthesic time
(minutes)</bold></th><th rowspan="2" align="center" colspan="1"><bold>ES</bold></th><th colspan="2" align="center" rowspan="1"><bold>Surgical time
(minutes)</bold></th><th rowspan="2" align="center" colspan="1"><bold>ES</bold></th><th rowspan="2" align="center" valign="top" colspan="1"><bold>Need blood
transfusion</bold></th><th rowspan="2" align="center" colspan="1"><bold>ES</bold></th><th colspan="2" align="center" rowspan="1"><bold>Length of stay
(days)</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Mean</bold></th><th align="center" rowspan="1" colspan="1"><bold>SD</bold></th><th align="center" rowspan="1" colspan="1"><bold>Mean</bold></th><th align="center" rowspan="1" colspan="1"><bold>SD</bold></th><th align="center" rowspan="1" colspan="1"><bold>Mean</bold></th><th align="center" rowspan="1" colspan="1"><bold>SD</bold></th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Group A</td><td rowspan="1" colspan="1">Men</td><td align="center" rowspan="1" colspan="1">174.6</td><td align="center" rowspan="1" colspan="1">64.7</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">103.2</td><td align="center" rowspan="1" colspan="1">49.5</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">21.3%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">6.4</td><td align="center" rowspan="1" colspan="1">7.3</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Women</td><td align="center" rowspan="1" colspan="1">170.1</td><td align="center" rowspan="1" colspan="1">32.5</td><td align="center" rowspan="1" colspan="1">95.3</td><td align="center" rowspan="1" colspan="1">26.8</td><td align="center" rowspan="1" colspan="1">40.9%</td><td align="center" rowspan="1" colspan="1">5.5</td><td align="center" rowspan="1" colspan="1">2.4</td></tr><tr><td rowspan="2" colspan="1">Group B</td><td rowspan="1" colspan="1">Men</td><td align="center" rowspan="1" colspan="1">179.4</td><td align="center" rowspan="1" colspan="1">48.5</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">105.8</td><td align="center" rowspan="1" colspan="1">34.6</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">25%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">5.6</td><td align="center" rowspan="1" colspan="1">3.3</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Women</td><td align="center" rowspan="1" colspan="1">170.1</td><td align="center" rowspan="1" colspan="1">32.5</td><td align="center" rowspan="1" colspan="1">95.3</td><td align="center" rowspan="1" colspan="1">26.8</td><td align="center" rowspan="1" colspan="1">50%</td><td align="center" rowspan="1" colspan="1">5.5</td><td align="center" rowspan="1" colspan="1">2.4</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>SS=statistical significance; Y=yes; N=no; SD=standard deviation</p></fn></table-wrap-foot></table-wrap>
</p><p><table-wrap id="t6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Gender and intraoperative complications, reintervention, thirty-day
complications and thirty-day mortality (Groups A and B).</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><thead><tr><th colspan="2" rowspan="2" align="left">&#x000a0;</th><th align="center" rowspan="1" colspan="1"><bold>Intraoperative</bold></th><th rowspan="2" align="center" colspan="1"><bold>ES</bold></th><th colspan="6" align="center" rowspan="1"><bold>Re-intervention</bold></th><th align="center" rowspan="1" colspan="1"><bold>Thirty-day</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th><th align="center" rowspan="1" colspan="1"><bold>Thirty-day</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>complications</bold></th><th align="center" rowspan="1" colspan="1"><bold>General</bold></th><th align="center" rowspan="1" colspan="1"><bold>SS</bold></th><th align="center" rowspan="1" colspan="1"><bold>Endoleak IA</bold></th><th align="center" rowspan="1" colspan="1"><bold>SS</bold></th><th align="center" rowspan="1" colspan="1"><bold>Endoleak IB</bold></th><th align="center" rowspan="1" colspan="1"><bold>SS</bold></th><th align="center" rowspan="1" colspan="1"><bold>complications</bold></th><th align="center" rowspan="1" colspan="1"><bold>mortality</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Group A</td><td align="center" rowspan="1" colspan="1">Men</td><td align="center" rowspan="1" colspan="1">23.6%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">16.1%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">4.3%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">4.3%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">22.7%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">1.20%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Women</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Group B</td><td align="center" rowspan="1" colspan="1">Men</td><td align="center" rowspan="1" colspan="1">25.5%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">19.1%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">14.3%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">0</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">28.6%</td><td rowspan="2" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">2.10%</td><td rowspan="2" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Women</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>SS=statistical significance; Y=yes; N=no</p></fn></table-wrap-foot></table-wrap>
</p><p>Kaplan Meier curves of postoperative survival by patient's gender show a better
survival in men but without statistical significance. The median survival in men was
8.5 years, with a standard deviation of 0.5 (95% CI: 7.5-9.5), and 4.6 years in
women, with a standard deviation of 0.83 (95% CI: 3-6.2). We can see both survival
curves in <xref ref-type="fig" rid="f1">Figure 1</xref>, and there was no
statistical significance between them.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The surgical indication for AAA is mainly based in two randomized trials<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>. These studies have shown the benefit of surgery to patients
with aortic aneurysms over 5.5 cm, with criteria equal for both genders. However, in
these studies there were 83% and 99.2% of males, and so it can be questioned if the
treatment proposed can be extended for both genders. Likewise, the 3 cm diameter
needed to diagnose an AAA must be questioned if it is suitable for both genders,
considering that characteristics like height, body surface and weight are different
between males and females.</p><p>The larger randomized prospective studies (EVAR-1<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>, DREAM<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, OVER<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>,
ACE<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> and
EVAR-2<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>) that compared
open surgery to EVAR and are seen as references to AAA treatment have a male
percentage of 91%, 93%, 99.3%, 100% and 76.8%, respectively. This huge difference
makes us wonder if it is reasonable to extrapolate the results to women. Menezes et
al. <sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> also has demonstrated
this discrepancy in a retrospective regional study, with a male percent of
91.21%.</p><p>Due to a lower prevalence of AAA in women, they are excluded from screening programs,
but Wanhainen et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> suggest
that the prevalence may be underestimated. They state that if the criteria to
diagnose an AAA changes from 3 cm in diameter to 1.5 times the diameter of the
normal infra-renal aorta, then the prevalence in the age group from 65 to 75 years
would go from 16.9% to 12.9% in men and from 3.5% to 9.8% in women.</p><p>Mofidi et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> suggest that
aneurysm growth is higher in women than in men (3.67 mm/year in women vs. 2.03
mm/year in men, <italic>P</italic>&#x0003c;0.001). The UK small aneurysm trial also
revealed a risk of rupture four times higher in women, and a risk of rupture with
lower diameters (5.0&#x000b1;0.8 cm in women vs. 6.0&#x000b1;1.4 cm in men,
<italic>P</italic>=0.001).</p><p>In 2006, Dillavou et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>
revealed that EVAR was done to 28% of the women with AAA and to 44.3% in men. It is
supposed that a worse profile of anatomical conditions in women explained this
difference.</p><p>As for 30-day mortality rate, it was reported to be higher in women undergoing
elective surgery and in rupture. Norman &#x00026; Powell's review stated that fatality
after elective surgery was 35% to 50% higher in women<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Heller et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> reported a mortality rate after conventional surgery of
7.7% in women and 5.1% in men. Leon et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> confirmed this mortality difference after conventional
surgery, with a mortality of 8.2% in women and 5.2% in men, and after EVAR this
difference was even higher: 5.1% in women <italic>vs.</italic> 1.7% in men. In a
meta-analysis, Grootenboer et al.<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup> gathered 61 studies for a total of 516.118 patients and showed
that women with AAA had a higher mortality rate comparing to men in the elective
treatment by conventional surgery (7.6% <italic>vs.</italic> 5.1%) and in EVAR (2.9%
<italic>vs.</italic> 1.5%).</p><p>One should also account for the higher survival in women and their different
physiology: until menopause women have hormonal protection; after, this protection
is lost, and they have a higher incidence of cardiovascular disease comparing to
men.</p><p>Starr &#x00026; Halpern<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> reviewed
the current recommendations and recent literature, to help finding the differences
between gender. Their review showed that women presented later, have a higher
rupture rate, and underwent AAA treatment less than men, and with varied outcomes,
with some studies showing similar short-term and long-term results between men and
women. They concluded that it must be some genderspecific risks inherent to women,
although pathophysiologic mechanisms responsible for the difference in AAA
prevalence between gender have not been determined. They affirmed that it is
reasonable to recommend routine screening for women older than sixty-five years who
have ever smoked or who have a family history of AAA and the need of additional
research to elucidate the reasons for differences between men and women.</p><p>Skibba et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>, in a 14-year
retrospective study with 2121 patients and 499 women (23.5%), found that women with
AAA were older than men, have a higher frequency of cardiovascular risk factors, had
greater risk of rupture at all size intervals and a fourfold increased frequency of
rupture at &#x0003c;5.5 cm.</p><p>Preiss et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> searched the
differences in late mortality between females undergoing elective EVAR for small
and/or slow-growing AAAs compared with those who meet standard criteria at their
institution. They analyzed thirty-six women (22% of treated patients) for a mean
follow-up time of 37.2 months. Sixteen of the thirty-six women (44.4%) presented an
AAA diameter smaller than 5.5 cm or a six-month growing rate shorter than 0.5 cm.
This group had a higher late mortality (37.5% <italic>vs.</italic> 5%;
<italic>P</italic>=0.03) and a trend toward increased reoperation rate. This
fact might compromise the EVAR indication in women who do not meet the standard
criteria.</p><p>Gloviczki et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> analyzed the
outcome results of consecutive patients who underwent EVAR between 1997 and 2011 at
a tertiary center, with a total of 934 patients (13% female). They concluded that
women had an increased rate of complications and reinterventions, but not a
significantly higher mortality.</p><p>Chung et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> analyzed 1380
consecutive patients who underwent elective EVAR from 1992 to 2012, of which 214
were women. They referred that women were older and had less cardiac disease, had
shorter necks and more angulated, had less iliac aneurysms and they need more
adjunctive arterial procedures, with more perioperative complications, longer length
of stay and higher rate of endoleaks. Despite more complex aneurysm anatomy and more
perioperative complications, aneurysmrelated deaths and overall survival was similar
between genders.</p><p>Ayo et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>, in a retrospective
single institution review, showed women with greater neck angulation and higher
percent of thrombus, but with advantage in incidence of type I endoleaks (3.5% in
men <italic>vs.</italic> 0% in women, <italic>P</italic>=0.381) and overall
reinterventions rate (11.3% in men <italic>vs.</italic> 0% in women,
<italic>P</italic>&#x0003c;0.05).</p><p>In our experience, EVAR and open surgery were offered independently of the gender,
women were older (<italic>P</italic>&#x0003c;0.05) and had fewer association with
smoking, ischemic heart disease, and vascular neurological disease. Concerning the
anatomical characteristics, women are more associated to neck angulation &#x0003e;70&#x000ba;.
Besides these anatomical findings, there was no statistical difference in the
outcomes of EVAR between the genders.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Despite the absence of significant numbers conditioned by the small sample, and
despite the inherent limitation of a retrospective non-randomized study, our study
shows a clear difference in the clinical and anatomical characteristics of the
aneurysms among men and women, but with the same results of EVAR. This should be
explored in order to understand the influence of gender in the etiology of AAA.</p><p><table-wrap id="t8" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">RM</td><td rowspan="1" colspan="1">Conception and design study; operations and/or trials
performance; analysis and/or data interpretation; manuscript
writing or critical review of its content; final manuscript
approval</td></tr><tr><td rowspan="1" colspan="1">GT</td><td rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td rowspan="1" colspan="1">PO</td><td rowspan="1" colspan="1">Statistical analysis; final manuscript approval</td></tr><tr><td rowspan="1" colspan="1">LL</td><td rowspan="1" colspan="1">Operations and/or trials performance; final manuscript
approval</td></tr><tr><td rowspan="1" colspan="1">CP</td><td rowspan="1" colspan="1">Operations and/or trials performance; final manuscript
approval</td></tr><tr><td rowspan="1" colspan="1">RA</td><td rowspan="1" colspan="1">Final manuscript approval</td></tr></tbody></table></table-wrap>
</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflicts of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Hospital de Santo Ant&#x000f3;nio - Centro Hospitalar do
Porto, Porto, Portugal.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeRubertis</surname><given-names>BG</given-names></name><name><surname>Trocciola</surname><given-names>SM</given-names></name><name><surname>Ryer</surname><given-names>EJ</given-names></name><name><surname>Pieracci</surname><given-names>FM</given-names></name><name><surname>McKinsey</surname><given-names>JF</given-names></name><name><surname>Faries</surname><given-names>Pl</given-names></name><etal/></person-group><article-title>Abdominal aortic aneurysm in women: prevalence, risk factors, and
implications for screening</article-title><source>J Vasc Surg</source><year>2007</year><volume>46</volume><issue>4</issue><fpage>630</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">17903646</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>PE</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name></person-group><article-title>Abdominal aortic aneurysm: the prognosis in women is worse than
in men</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>22</issue><fpage>2865</fpage><lpage>2869</lpage><pub-id pub-id-type="pmid">17548742</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>JA</given-names></name><name><surname>Weinberg</surname><given-names>A</given-names></name><name><surname>Arons</surname><given-names>R</given-names></name><name><surname>Krishnasastry</surname><given-names>KV</given-names></name><name><surname>Lyon</surname><given-names>RT</given-names></name><name><surname>Deitch</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Two decades of abdominal aortic aneurysm repair: have we made any
progress?</article-title><source>J Vasc Surg</source><year>2000</year><volume>32</volume><issue>6</issue><fpage>1091</fpage><lpage>1100</lpage><pub-id pub-id-type="pmid">11107080</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon</surname><given-names>LR</given-names><suffix>Jr</suffix></name><name><surname>Labropoulos</surname><given-names>N</given-names></name><name><surname>Laredo</surname><given-names>J</given-names></name><name><surname>Rodriguez</surname><given-names>HE</given-names></name><name><surname>Kalman</surname><given-names>PG</given-names></name></person-group><article-title>To what extent has endovascular aneurysm repair influenced
abdominal aortic aneurysm management in the state of
Illinois?</article-title><source>J Vasc Surg</source><year>2005</year><volume>41</volume><issue>4</issue><fpage>568</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">15874918</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grootenboer</surname><given-names>N</given-names></name><name><surname>Sambeek</surname><given-names>MV</given-names></name><name><surname>Arends</surname><given-names>L</given-names></name><name><surname>Hendriks</surname><given-names>J</given-names></name><name><surname>Hunink</surname><given-names>M</given-names></name><name><surname>Bosch</surname><given-names>J</given-names></name></person-group><article-title>Systematic review and metaanalysis of sex differences in outcome
after intervention for abdominal aortic aneurysm</article-title><source>Br J Surg</source><year>2010</year><volume>97</volume><issue>8</issue><fpage>1169</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">20564307</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skibba</surname><given-names>AA</given-names></name><name><surname>Evans</surname><given-names>JR</given-names></name><name><surname>Hopkins</surname><given-names>SP</given-names></name><name><surname>Yoon</surname><given-names>HR</given-names></name><name><surname>Katras</surname><given-names>T</given-names></name><name><surname>Kalbfleisch</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Reconsidering gender relative to risk of rupture in the
contemporary management of abdominal aortic aneurysms</article-title><source>J Vasc Surg</source><year>2015</year><volume>62</volume><issue>6</issue><fpage>1429</fpage><lpage>1436</lpage><pub-id pub-id-type="pmid">26409846</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>U.K.</collab></person-group><article-title>Small Aneurysm Trial: design, methods and progress. The UK Small
Aneurysm Trial participants</article-title><source>Eur J Vasc Endovasc Surg</source><year>1995</year><volume>9</volume><issue>1</issue><fpage>42</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">7664011</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>F</given-names></name><name><surname>Wilson</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>G</given-names></name><name><surname>Reinke</surname><given-names>D</given-names></name><name><surname>Littooy</surname><given-names>F</given-names></name><name><surname>Acher</surname><given-names>C</given-names></name><etal/></person-group><article-title>Immediate repair compared with surveillance of small abdominal
aortic aneuryms</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>19</issue><fpage>1437</fpage><lpage>1444</lpage><pub-id pub-id-type="pmid">12000813</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>L</given-names></name><name><surname>Kwong</surname><given-names>G</given-names></name><name><surname>Powell</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>S</given-names></name></person-group><article-title>Comparison of endovascular aneurysm repair with open repair in
patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative
mortality results: randomised controlled trial</article-title><source>Lancet</source><year>2004</year><volume>364</volume><issue>9437</issue><fpage>843</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">15351191</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinssen</surname><given-names>M</given-names></name><name><surname>Verhoeven</surname><given-names>E</given-names></name><name><surname>Buth</surname><given-names>J</given-names></name><name><surname>Cuypers</surname><given-names>P</given-names></name><name><surname>Sambeek</surname><given-names>MV</given-names></name><name><surname>Balm</surname><given-names>R</given-names></name><etal/></person-group><article-title>A randomized trial comparing conventional and endovascular repair
of abdominal aortic aneurysms</article-title><source>N Engl J Med</source><year>2004</year><volume>351</volume><issue>16</issue><fpage>1607</fpage><lpage>1618</lpage><pub-id pub-id-type="pmid">15483279</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Freischlag</surname><given-names>JA</given-names></name><name><surname>Kyriakides</surname><given-names>TC</given-names></name><name><surname>Matsumura</surname><given-names>JS</given-names></name><name><surname>Padberg</surname><given-names>FT</given-names><suffix>Jr</suffix></name><name><surname>Kohler</surname><given-names>TR</given-names></name><etal/></person-group><article-title>Long-term comparison of endovascular and open repair of abdominal
aortic aneurysm</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><issue>21</issue><fpage>1988</fpage><lpage>1997</lpage><pub-id pub-id-type="pmid">23171095</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becquemin</surname><given-names>J</given-names></name><name><surname>Pillet</surname><given-names>J</given-names></name><name><surname>Lescalie</surname><given-names>F</given-names></name><name><surname>Sapoval</surname><given-names>M</given-names></name><name><surname>Goueffic</surname><given-names>Y</given-names></name><name><surname>Lermusiaux</surname><given-names>P</given-names></name><etal/></person-group><article-title>A randomized controlled trial of endovascular aneurysm repair
versus open surgery for abdominal aortic aneurysms in low- to moderate-risk
patients</article-title><source>J Vasc Surg</source><year>2011</year><volume>53</volume><issue>5</issue><fpage>1167</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">21276681</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>EVAR trial participants</collab></person-group><article-title>Endovascular aneurysm repair and outcome in patients unfit for
open repair of abdominal aortic aneurysm (EVAR trial 2): randomised
controlled trial</article-title><source>Lancet</source><year>2005</year><volume>365</volume><issue>9478</issue><fpage>2187</fpage><lpage>2192</lpage><pub-id pub-id-type="pmid">15978926</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>FH</given-names></name><name><surname>Ferrarezi</surname><given-names>B</given-names></name><name><surname>Souza</surname><given-names>MA</given-names></name><name><surname>Cosme</surname><given-names>SL</given-names></name><name><surname>Molinari</surname><given-names>GJ</given-names></name></person-group><article-title>Results of open and endovascular abdominal aortic aneurysm repair
according to the E-PASS Score</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>1</issue><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">27074271</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanhainen</surname><given-names>A</given-names></name><name><surname>Lundkvist</surname><given-names>J</given-names></name><name><surname>Bergqvist</surname><given-names>D</given-names></name><name><surname>Bjorck</surname><given-names>M</given-names></name></person-group><article-title>Cost-effectiveness of screening women for abdominal aortic
aneurysm</article-title><source>J Vasc Surg</source><year>2006</year><volume>43</volume><issue>5</issue><fpage>908</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">16678681</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mofidi</surname><given-names>R</given-names></name><name><surname>Goldie</surname><given-names>V</given-names></name><name><surname>Kelman</surname><given-names>J</given-names></name><name><surname>Dawson</surname><given-names>A</given-names></name><name><surname>Murie</surname><given-names>J</given-names></name><name><surname>Chalmers</surname><given-names>R</given-names></name></person-group><article-title>Influence of sex on expansion rate of abdominal aortic
aneurysms</article-title><source>Br J Surg</source><year>2007</year><volume>94</volume><issue>3</issue><fpage>310</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">17262754</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillavou</surname><given-names>ED</given-names></name><name><surname>Muluk</surname><given-names>SC</given-names></name><name><surname>Makaroun</surname><given-names>MS</given-names></name></person-group><article-title>A decade of change in abdominal aortic aneurysm repair in the
United States: have we improved outcomes equally between men and
women?</article-title><source>J Vasc Surg</source><year>2006</year><volume>43</volume><issue>2</issue><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">16476592</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>JE</given-names></name><name><surname>Halpern</surname><given-names>V</given-names></name></person-group><article-title>Abdominal aortic aneurysms in women</article-title><source>J Vasc Surg</source><year>2013</year><volume>57</volume><issue>4</issue><supplement>Suppl</supplement><fpage>3S</fpage><lpage>10S</lpage></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preiss</surname><given-names>JE</given-names></name><name><surname>Arya</surname><given-names>S</given-names></name><name><surname>Duwayri</surname><given-names>Y</given-names></name><name><surname>Shafii</surname><given-names>SM</given-names></name><name><surname>Veeraswamy</surname><given-names>RK</given-names></name><name><surname>Rajani</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Late mortality in females after endovascular aneurysm
repair</article-title><source>J Surg Res</source><year>2015</year><volume>198</volume><issue>2</issue><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">25976853</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloviczki</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Oderich</surname><given-names>GS</given-names></name><name><surname>Duncan</surname><given-names>AA</given-names></name><name><surname>Kalra</surname><given-names>M</given-names></name><name><surname>Fleming</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Clinical presentation, comorbidities, and age but not female
gender predict survival after endovascular repair of abdominal aortic
aneurysm</article-title><source>J Vasc Surg</source><year>2015</year><volume>61</volume><issue>4</issue><fpage>853</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">25595402</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>C</given-names></name><name><surname>Tadros</surname><given-names>R</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Ellozy</surname><given-names>S</given-names></name><name><surname>Faries</surname><given-names>P</given-names></name><etal/></person-group><article-title>Evolution of gender-related differences in outcomes from two
decades of endovascular aneurysm repair</article-title><source>J Vasc Surg</source><year>2015</year><volume>61</volume><issue>4</issue><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">25595407</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayo</surname><given-names>D</given-names></name><name><surname>Blumberg</surname><given-names>SN</given-names></name><name><surname>Gaing</surname><given-names>B</given-names></name><name><surname>Baxter</surname><given-names>A</given-names></name><name><surname>Mussa</surname><given-names>FF</given-names></name><name><surname>Rockman</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Gender differences in aortic neck morphology in patients with
abdominal aortic aneurysms undergoing elective endovascular aneurysm
repair</article-title><source>Ann Vasc Surg</source><year>2016</year><volume>30</volume><fpage>100</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">26541967</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Type of endoleak by gender (Groups A and B).</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><thead><tr><th rowspan="2" align="left" colspan="1">&#x000a0;</th><th colspan="2" align="center" rowspan="1"><bold>Group A</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th><th colspan="2" align="center" rowspan="1"><bold>Group B</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Men</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women</bold></th><th align="center" rowspan="1" colspan="1"><bold>Men</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">No endoleak</td><td align="center" rowspan="1" colspan="1">59.4%</td><td align="center" rowspan="1" colspan="1">60%</td><td rowspan="4" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">68.90%</td><td align="center" rowspan="1" colspan="1">60%</td><td rowspan="4" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Endoleak I or III</td><td align="center" rowspan="1" colspan="1">10.3%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">8.90%</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">Endoleak II</td><td align="center" rowspan="1" colspan="1">24.5%</td><td align="center" rowspan="1" colspan="1">30%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">30%</td></tr><tr><td rowspan="1" colspan="1">Endoleak II + I/III</td><td align="center" rowspan="1" colspan="1">5.8%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">2.20%</td><td align="center" rowspan="1" colspan="1">10%</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>SS=statistical significance; Y=yes; N=no</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Aneurysmal sac behaviour after EVAR (Groups A and B).</p></caption><table frame="box" rules="all" style="border-right:hidden;border-left:hidden"><thead><tr><th rowspan="2" align="left" colspan="1">&#x000a0;</th><th colspan="2" align="center" rowspan="1"><bold>Group A</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th><th colspan="2" align="center" rowspan="1"><bold>Group B</bold></th><th rowspan="2" align="center" colspan="1"><bold>SS</bold></th></tr><tr><th align="center" rowspan="1" colspan="1"><bold>Men</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women</bold></th><th align="center" rowspan="1" colspan="1"><bold>Men</bold></th><th align="center" rowspan="1" colspan="1"><bold>Women</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Sac growth</td><td align="center" rowspan="1" colspan="1">10.9%</td><td align="center" rowspan="1" colspan="1">10%</td><td rowspan="9" align="center" colspan="1">N</td><td align="center" rowspan="1" colspan="1">14%</td><td align="center" rowspan="1" colspan="1">10%</td><td rowspan="9" align="center" colspan="1">N</td></tr><tr><td rowspan="1" colspan="1">Sac shrinkage</td><td align="center" rowspan="1" colspan="1">89.4%</td><td align="center" rowspan="1" colspan="1">90%</td><td align="center" rowspan="1" colspan="1">86%</td><td align="center" rowspan="1" colspan="1">90%</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;0-5 mm</td><td align="center" rowspan="1" colspan="1">21.8%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">20.9%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;5-10 mm</td><td align="center" rowspan="1" colspan="1">32.7%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">25.6%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;10-15 mm</td><td align="center" rowspan="1" colspan="1">12.2%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">18.6%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;15-20 mm</td><td align="center" rowspan="1" colspan="1">9.5%</td><td align="center" rowspan="1" colspan="1">10%</td><td align="center" rowspan="1" colspan="1">11.6%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;20-25 mm</td><td align="center" rowspan="1" colspan="1">4.8%</td><td align="center" rowspan="1" colspan="1">20%</td><td align="center" rowspan="1" colspan="1">4.7%</td><td align="center" rowspan="1" colspan="1">20%</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;25-30 mm</td><td align="center" rowspan="1" colspan="1">4.1%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2.3%</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003e; 30 mm</td><td align="center" rowspan="1" colspan="1">4.1%</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2.3%</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>SS=statistical significance; Y=yes; N=no</p></fn></table-wrap-foot></table-wrap></floats-group></article>